Merck’s stock tumbled 6% early Tuesday, after the drug company’s softer-than-expected guidance for the current year offset ...
Merck (NYSE: MRK) recently released its Q4 results, with revenues and earnings exceeding the street estimates.
7don MSNOpinion
President Donald Trump’s Health and Human Services nominee said he will divest his interest in lawsuits against an HPV ...
Merck’s full-year 2025 revenue guidance fell short of what some analysts were expecting, at a range of $64.1 billion to $65.6 ...
Sen. Elizabeth Warren, D-Mass., questions Robert F. Kennedy Jr., President Donald Trump's pick for Department of Health and Human Services secretary, as he testifies before the Senate Finance ...
continues to support the safety and efficacy profiles of our HPV vaccines," Rahway, New Jersey-based Merck said Tuesday in a statement on the litigation. "The plaintiff's allegations have no merit ...
The lawsuit alleges marketing fraud against pharmaceutical company Merck for its HPV vaccine, Gardasil, which Merck denies. The Centers for Disease Control and Prevention (CDC) maintains that the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results